Vis enkel innførsel

dc.contributor.authorOmlin, A.
dc.contributor.authorBlum, David
dc.contributor.authorWierecky, J
dc.contributor.authorHaile, SR
dc.contributor.authorOttery, Faith
dc.contributor.authorStrasser, F
dc.date.accessioned2019-10-28T08:01:38Z
dc.date.available2019-10-28T08:01:38Z
dc.date.created2013-12-03T13:27:32Z
dc.date.issued2013
dc.identifier.citationJournal of Cachexia, Sarcopenia and Muscle. 2013, 4 (1), 55-61.nb_NO
dc.identifier.issn2190-5991
dc.identifier.urihttp://hdl.handle.net/11250/2624764
dc.description.abstractBackground Involuntary weight loss (IWL) is frequent in advanced cancer patients causing compromised anticancer treatment outcomes and function. Cancer cachexia is influenced by nutrition impact symptoms (NIS). The aim of this study was to explore the frequency of NIS in advanced patients and to assess specific interventions guided by a 12‐item NIS checklist. Methods Consecutive patients from an outpatient nutrition‐fatigue clinic completed the NIS checklist. The NIS checklist was developed based on literature review and multiprofessional clinical expert consensus. Chart review was performed to detect defined NIS typical interventions. Oncology outpatients not seen in the nutrition‐fatigue clinic were matched for age, sex, and tumor to serve as controls. Results In 52 nutrition‐fatigue clinic patients, a mixed cancer population [IWL in 2 months 5.96 % (mean)], the five most frequent NIS were taste and smell alterations 27 %, constipation 19 %, abdominal pain 14 %, dysphagia 12 %, and epigastric pain 10 %. A statistically significant difference for NIS typical interventions in patients with taste and smell alterations (p = 0.04), constipation (p = 0.01), pain (p = 0.0001), and fatigue (p = 0.0004) were found compared to the control population [mixed cancer, 3.53 % IWL in 2 months (mean)]. Conclusion NIS are common in advanced cancer patients. The NIS checklist can guide therapeutic nutrition‐targeted interventions. The awareness for NIS will likely evoke more research in assessment, impact, and treatment.nb_NO
dc.language.isoengnb_NO
dc.publisherWileynb_NO
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleNutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case-control studynb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber55-61nb_NO
dc.source.volume4nb_NO
dc.source.journalJournal of Cachexia, Sarcopenia and Musclenb_NO
dc.source.issue1nb_NO
dc.identifier.doi10.1007/s13539-012-0099-x
dc.identifier.cristin1072050
dc.description.localcode© 2013 The Authors. Published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial Licensenb_NO
cristin.unitcode194,65,15,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal